Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Retrovirology. Author manuscript; available in PMC 2010 July 21.
Published in final edited form as:
Retrovirology. 2008; 2: 1–10.
PMCID: PMC2908044

Pathogenesis of Human Immunodeficiency Virus Type-1 (HIV-1)-Associated Dementia: Role of Voltage-Gated Potassium Channels


HIV-1-associated dementia (HAD) describes the cognitive impairments and behavioral disturbances which afflict many HIV-infected individuals. Although the incidence of HAD has decreased significantly in the era of HAART, it remains a significant complication of HIV-1 infection as patients with acquired immune deficient syndrome (AIDS) live longer, antiretroviral drugs remain unable to effectively cross the blood-brain barrier (BBB), and HIV-1 resistance grows due to viral strain mutation. Although the precise mechanism leading to HAD is incompletely understood, it is commonly accepted its progression involves a critical mass of infected and activated mononuclear phagocytes (MP; brain perivascular macrophages and microglia) releasing immune and viral products in brain. These cellular and viral products induce neuronal dysfunction and injury via various signaling pathways. Emerging evidence indicates that voltage-gated potassium (Kv) channels, key regulators of cell excitability and animal behavior (learning and memory), are involved in the pathogenesis of HAD/HAND. Here we survey the literature and find HAD related alterations in cellular and viral products can alter MP and neuronal Kv channel activity, leading to MP and neuronal dysfunction and cognitive deficits. Thus, MP and neuronal Kv channels may be a new target in the effort to develop therapies for HAD and perhaps other inflammatory neurodegenerative disorders.

Keywords: voltage-gated K channels, macrophages, neurons, HIV, AIDS, HIV-1-associated dementia


Human immunodeficiency virus type-1 (HIV-1)-associated dementia (HAD), a severe form of HIV-1-associated neurocognitive disorders (HAND) (Antinori et al. 2007), describes the cognitive deficits, motor disturbances, and behavioral abnormalities often observed in HIV-infected individuals (Kaul et al. 2001; McArthur et al. 2003; Gonzalez-Scarano and Martin-Garcia, 2005; Kramer-Hammerle et al. 2005; Verani et al. 2005). Although the incidence has significantly decreased since the advent of highly active anti-retroviral therapy (HAART), HAD remains a significant complication of HIV-1 infection as patients with acquired immune deficient syndrome (AIDS) live longer, antiretroviral drugs remain unable to effectively cross the blood-brain barrier (BBB), and HIV-1 resistance grows due to viral strain mutation. Despite more than two decades of investigation, our understanding of the mechanisms for HAD pathogenesis remains incomplete. It is widely accepted that HIV-1-infected MPs (brain perivascular macrophages and microglia) secrete soluble viral and cellular factors causing neuronal dysfunction and damage (Kaul et al. 2001; McArthur et al. 2003; Gonzalez-Scarano and Martin-Garcia, 2005; Kramer-Hammerle et al. 2005; Verani et al. 2005), leading to cognitive impairment. How soluble viral and cellular factors induce cognitive impairment is not fully understood. Emerging evidence indicates that voltage-gated potassium (Kv) channels, key regulators of neuronal excitability and macrophage secretory activity, are involved in the pathophysiological processes of several neurodegenerative disorders (Judge and Bever, 2006; Judge et al. 2006) and in animal behavior (i.e. learning and memory) (Giese et al. 1998; Giese et al. 2001; Solntseva et al. 2003). This review aims at updating our understanding of the role played by Kv channels in HIV-1-associated neuropathology. As Kv channels are expressed on both macrophages and neurons, alteration of the Kv channel activity by soluble viral and cellular factors may result in macrophage and neuronal dysfunction, leading to HAND/HAD. Thus, understanding the role played by Kv channels in HAND/HAD pathogenesis could provide molecular and cellular targets for the development of new therapies.

Macrophage Kv Channels and Macrophage-Associated Neurodegeneration

Macrophages and HAD neuropathology

Several different macrophage populations exist in the central nervous system (CNS), including transient perivascular macrophages and resident microglia. In healthy individuals, these populations support critical immune and homeostatic functions without pathological consequences (Cotter et al. 2002; Williams and Hickey, 2002). However, under certain circumstances a cycle of macrophage activation can cause neurotoxicity through excessive secretion of inflammatory and immunoactive substances. One such scenario is thought to unfold with HIV-1 infection, wherein transient populations of macrophage carry HIV-1 across the BBB (Gartner, 2000). Indeed, early autopsies of HIV-1 encephalitis (HIVE) patients found extensive monocyte-macrophage brain infiltration, formation of multinucleated giant cells (MNGC), and excess cellularity primarily of macrophage lineage (Michaels et al. 1988b). In situ hybridization (Stoler et al. 1986) and viral antigen co-localization studies (Gabuzda et al. 1986; Michaels et al. 1988a; Kure et al. 1991) also confirmed the primary cellular targets for HIV-1 in the brain are macrophage and microglia (Koenig et al. 1986; Wiley et al. 1986; Meltzer et al. 1990).

Importantly, progression to HAD is well correlated with high numbers of macrophage and microglia in the CNS, even more so than the extent of HIV-1 infection itself (Budka, 1986; Glass et al. 1995). Once in the CNS, infected macrophage provide a sanctuary for the HIV-1 virus (Koenig et al. 1986; Genis et al. 1992; Gendelman, 1997a), while producing immunoactive and inflammatory substances such as viral proteins, proinflammatory cytokines, chemokines, excitatory amino acids, nitric oxide, and eicosanoids. In addition to promoting further entry and activation of macrophage, many of these substances have been shown to cause electrophysiological disturbances (Koller et al. 1997; Nath and Geiger, 1998; Balschun et al. 2004; Gonzalez-Scarano and Martin-Garcia, 2005; Verani et al. 2005) and may mediate neuronal dysfunction and/or death (Cotter et al. 1999; Kaul et al. 2001). Therefore, macrophage play a critical role in the pathogenesis HIVE and HAD by mediating viral entry into the CNS, harboring viral reservoirs, promoting further macrophage migration, producing neurotoxic substances, and participating in tissue destructive processes.

Macrophage Kv channels and neurotoxicity

Kv channels primarily function to set resting membrane potentials and repolarize actions potentials in excitable cells. While not typically thought of as electrically excitable cells, human and mouse macrophage have been found to express Kv channels, including Kv1.3 and Kv1.5 (Gallin, 1991; Mackenzie et al. 2003; Park et al. 2003; Vicente et al. 2003). In particular, elevated Kv1.3 expression in periventricular and parenchymal inflammatory infiltrates has been observed in multiple sclerosis patients (Rus et al. 2005), revealing a possible connection to neurological dysfunction. The importance of Kv channel activity in macrophage can be seen in its variable expression level, which depends on the state of activation of the cell (Blunck et al. 2001; Vicente et al. 2003). While patch clamp experiments have shown that freshly isolated monocytes exhibit low numbers of Kv channels, this expression increases significantly during monocyte differentiation to macrophage (Blunck et al. 2001). This increase can be expected to result in greater outward Kv current, and occurs regardless of whether the stimulation leading to differentiation is macrophage colony stimulating factor (MCSF), exogenous lipopolysaccharide (LPS), phorbol myristate acetate (PMA), or HIV-1 Tat protein (Nelson et al. 1992; Schilling et al. 2000; Visentin et al. 2001; Qiu et al. 2002; Gerth et al. 2005).

While the precise functional role of these channels in macrophage has yet to be determined, membrane potential changes are among the earliest observed eventsafter stimulation. Mounting evidence suggests alterations in the Kv channel activity of macrophages may be a key early step in neuroinflammatory disorders, serving to initiate and/or amplify immune responses by controlling macrophage functions such as migration, proliferation, activation, and secretion (Gallin, 1991; Lewis and Cahalan, 1995; DeCoursey et al. 1996; Blunck et al. 2001; Qiu et al. 2002). For example, experiments with LPS-stimulated macrophages have revealed that increased voltage-dependent potassium channel conductance is necessary for macrophage activation and essential for cytokine production (Blunck et al. 2001). Similarly, MCSF and LPS were found to induce voltage-dependent potassium channel expression, while potassium channel blockade inhibited cell growth (proliferation) and nitric-oxide synthase production (activation) (Vicente et al. 2003). Furthermore, potassium channel blockers such as quinine, tetraethylammonium (TEA) chloride, and barium chloride, as well as increased extracellular potassium concentration, have been found to inhibit tumor necrosis factor-α (TNF-α) (Haslberger et al. 1992; Maruyama et al. 1994; Qiu et al. 2002) and inter-leukin-8 (IL-8) (Qiu et al. 2002) production by activated macrophages. Increased Kv channel conductance has also been linked to increased macrophage motility(Gendelman et al. 2008), which may result in more widespread inflammation. More recently, upregulation of Kv channel expression has been correlated with immune cell activation strongly enough to be considered a functional marker (Rus et al. 2005). Also, Kv channel blockers have now been used to alleviate neuropathology and symptoms in experimental autoimmune encephalomyelitis by reducing immune cell activation, proliferation, and production of interleukins and TNFα (Beeton et al. 2001). Collectively, this research implies increased Kv channel conductance may be a key first step in the activation, migration, proliferation, and secretion of macrophage. The regulation of macrophage activation and resultant cytokine production by Kv channels may mirror macrophage functional processes in vivo, where they are activated by various factors including those released by HIV-1- infected mononuclear phagocytes. As this is the consensus underlying upstream cause of HAD, these potassium channels are attractive targets for treatment.

Neuronal Kv Channels and HIV-1-Associated Neurodegeneration

Neuronal Kv channels and cell excitability

Kv channels are formed by the association of four α-helical subunits, which form homo- or heteromeric tetramers to create a functional channel (Coetzee et al. 1999). There are a number of unique subunits which, when combined with a susceptibility to modulation by diverse factors, account for the large functional variation of these channels. Kv channels are categorized based on their voltage sensitivity (low- or high-voltage-activated) and inactivation tendencies (delayed rectifier (Ik) or A-type (IA) (Dodson and Forsythe, 2004). Regardless of the type of Kv channel, the negative equilibrium potential of K+ relative to the action potential threshold lends an essentially inhibitory nature to K+ currents. Collectively, Kv channels set and stabilize resting membrane potential, repolarize action potentials (APs), and control the discharge frequency by regulating inter-spike intervals, thereby play a crucial role in the generation of neuronal electrical activity and directly influencing neuronal excitability. As mentioned, Kv channels can be modulated by a number of different factors, including membrane potential, redox potential, post-translational modification, organic molecules, peptides (Hille, 2001; Birnbaum et al. 2004), and other bioactive molecules such as proinflammatory cytokines. Thus, irregular modulation of Kv channel activity could lead to neuronal dysfunction and disrupt cognition.

Neuronal Kv channels and learning and memory

Recent genetic targeting studies indicate that Kv channel activity is of great importance in memory processes (Giese et al. 1998; Giese et al. 2001; Solntseva et al. 2003). As the number and pattern of APs are thought to encode information (Reike et al. 1997), Kv channel dysfunction may alter information processing and therefore be an important link in memory disturbances. Experiments in several different model systems have now shown decreased K+ channel current correlates with improved memory and long-term potentiation (LTP), while increased K+ current corresponds to learning and memory deficiencies (Ghelardini et al. 1998; Alkon, 1999; Solntseva et al. 2003). At present, the effect of altered potassium current is best characterized by studies of Kv4 channels in the distal dendrites, Kv1.1 and Kv2.1 in the proximal dendrites and soma, and Kv1 in axons and nerve terminals.

In particular, Kv4 channels are now thought to provide a convergence point for LTP signal transduction pathways (Olds et al. 1989; Alkon et al. 1998; Dineley et al. 2001; Birnbaum et al. 2004). Increasing or decreasing this A-type current inversely affects back-propagating AP (bp-AP) amplitudes (Watanabe et al. 2002), which helps determine the depolarization sensed by NMDA receptors and may underlie learning and memory networking properties (Paulsen and Sejnowski, 2000; Johnston et al. 2003; Birnbaum et al. 2004). Importantly, increased Kv4 current lowers LTP induction probability (Watanabe et al. 2002), while decreased Kv4 current enhances LTP (Frick et al. 2004), increases EPSP-spike (E-S) potentiation (Frick et al. 2004), and improves learning and memory (Lilliehook et al. 2003).

Kv1.1/Kvβ1.1 current has also been demonstrated to have an effect on alternative learning and memory mechanisms in subunit deletion studies (Giese et al. 1998; Giese et al. 2001; Murphy et al. 2004). The deletion of the Kvβ1.1 subunit causes a reduction in IA amplitude, which in turn reduces frequency-dependent spike-broadening and the slow after-hyperpolarization (sAHP). The end result is increased neuronal excitability, improved Morris watermaze performance, and a decreased threshold for the induction of LTP (Giese et al. 1998; Murphy et al. 2004).

Meanwhile, clusters of Kv2.1 channels regulate both intrinsic and neuronal excitability during high frequency stimulation (Murakoshi and Trimmer, 1999; Du et al. 2000; Pal et al. 2003). Dephosphorylation of Kv2.1 channels shifts their activation curves to more hyperpolarized potentials and increases their open channel probability (Murakoshi et al. 1997). The increased delayed rectifier current (IK) leads to a diminished LTP, which is reversible by re-phosphorylation, demonstrating a strong link to this potassium channel activity (Misonou et al. 2004).

Finally, several Kv1 subtypes have been implicated in gating axonal signal propagation (Debanne et al. 1997; Debanne et al. 1999), while suppressing hyperexcitability and reducing aberrant firing (David et al. 1995; Bajetto et al. 1999; Zhou et al. 1999) in both axons and presynaptic compartments (Dodson et al. 2003). In addition, in presynaptic compartments several subtypes contribute to raising the AP threshold (Dodson et al. 2003) and limiting the AP duration and related neurotransmitter release (Sekirnjak et al. 1997; Southan and Robertson, 2000; Elezgarai et al. 2003), while allowing for cumulative inactivation upon repeated depolarization to broaden the AP and enhance transmitter release (Jackson et al. 1991; Thorn et al. 1991). The relationship between these channels and learning and memory can be easily extrapolated from these results, but has yet to be explicitly demonstrated.

Neuronal Kv channels and apoptosis

Perhaps just as relevant as the electrophysiological consequences of increased neuronal Kv channel current is the ability of Kv channel activity to mediate apoptosis. The correlation between increased potassium channel current and apoptosis is robust and occurs across multiple cells types throughout the body, including smooth muscle cells, eosinophils, enterocytes, lymphocytes, thymocytes, T cells, and neurons (for reviews see (Yu, 2003; Burg et al. 2006). In repeated experiments, apoptotic volume decrease (AVD) and depression of apoptotic effectors were found to be mediated by K+ efflux and intracellular K+ depletion, leading to cell shrinkage, caspase activation, cytochrome c release, endonuclease activation, DNA fragmentation, and eventual apoptosis. In neurons these changes were accompanied by increased delayed rectifier K+ current and could be prevented by potassium channel blockers or medium with high K+ concentration (Yu et al. 1997; Wang et al. 2000; McLaughlin et al. 2001; Xiao et al. 2002). Therefore, while tissue homeostasis requires well regulated apoptosis, chronic increases in neuronal Kv current could initiate apoptotic sequences leading to premature cell death (i.e. neurodegeneration).

Neuronal Kv channels and HAD pathogenesis

Neuropsychiatric decline in AIDS patients is correlated with increasing numbers of macrophage in the brain (Glass et al. 1995), and the associated neuronal damage is closely associated with markers of macrophage activation (Adle-Biassette et al. 1999). This suggests the source of neuronal dysfunction may be the release of soluble factors from infected and/or activated macrophage. Cytokines, chemokines, excitatory amino acids, arachidonic acid metabolites, nitric oxide (NO), and viral proteins (HIV-1 gp120, Tat and Nef) are now thought to be the primary causes of HAD related neuronal injury (Lipton, 1991; Genis et al. 1992; Tyor et al. 1992; Gelbard et al. 1994; Toggas et al. 1994; Bukrinsky et al. 1995; Nottet and Gendelman, 1995; Xiong et al. 2000; Yeh et al. 2000; Kaul et al. 2001; Carlson et al. 2004). Emerging evidence indicates this damage could be mediated through excessive neuronal Kv channel activation.

Macrophage-conditioned media (MCM)

Whole cell patch clamp recordings performed in our lab have demonstrated immune-activated MCM increases both transient A-type current and delayed rectifier K+ current (Hu D et al. 2007; Keblesh et al. 2007). Using TEA, a Kv channel antagonist, it was possible to block the MCM-associated increase of IK. Furthermore, the biological relevance of this was assessed by neuronal viability in the presence or absence of TEA, allowing us to conclude the MCM-mediated Kv channel current is correlated with diminished cell survival.

Cellular factors: Cytokines

Two substances which are elevated in HAD and can increase neuronal potassium channel current are the proinflammatory cytokines TNF-α and interleukin-1β (IL-1β). Elevated synthesis (Epstein and Gendelman, 1993b; Gelbard et al. 1994) and release (Nicolini et al. 2001) of TNF-α has been demonstrated in several HAD experimental models. Also, analysis of patient brain tissue after autopsy has revealed increased TNF-α mRNA expression correlating with symptom severity (Glass et al. 1993). TNF-α is known to increase the permeability of the BBB to HIV-infected cells (Fiala et al. 1997), induce expression of cell adhesion molecules, and upregulate monocyte chemoattractant protein-1 (MCP-1) (Nottet, 2005). In addition, whole-cell patch-clamp recordings have now shown application of recombinant human TNF-α to cultured embryonic rat cerebral cortex neurons results in an increase of A-type K+ current (Houzen et al. 1997). Additional electrophysiological recordings revealed TNF-α applications inhibit LTP in the CA1 in a dose-dependent manner (Tancredi et al. 1992), while even low doses completely abolished LTP in the dentate gyrus (Cunningham et al. 1996).

A similar upregulation of IL-1β has also been observed in HAD patients and models (Genis et al. 1992; Epstein and Gendelman, 1993a; Nicolini et al. 2001; Zhao et al. 2001; Barak et al. 2002). IL-1β is also believed to induce cell adhesion molecule expression and upregulate MCP-1 (Brabers and Nottet, 2006). In addition, electro-physiological recordings demonstrate the application of IL-1β can increase both transient and delayed rectifier K+ currents in a dose-dependent manner (Szucs et al. 1992). This increased outward conductance causes synaptic inhibition and likely disrupts neuronal plasticity (Zeise et al. 1992), an idea supported by studies demonstrating pretreatment or superfusion of IL-1β diminishes LTP (Bellinger et al. 1993; Cunningham et al. 1996). In one notable experiment, i.c.v. injection of gp120 in rats stimulated IL-1β production and behavioral abnormalities, which could be attenuated with IL-1β antagonist pretreatment (Barak et al. 2002).

Cellular factors: AA, glutamate, BDNF

In addition to the aforementioned cytokines, several other cellular products are known to effect potassium channels, including arachidonic acid (AA), glutamate, and brain derived neurotrophic factor (BDNF). In a model for HAD, AA in HIV infected monocyte/glia co-cultures is converted to its metabolites at an abnormally high rate (Genis et al. 1992). Under normal conditions, AA suppresses IA current in CA1 pyramidal cells, thereby increasing the postsynaptic response to stimulation and lowering the threshold for LTP (Ramakers and Storm, 2002). In contrast, the metabolic products of AA have been found to dampen excitability by increasing the open channel probability (Piomelli et al. 1987) and the current (Zona et al. 1993) of sustained potassium channels. In HAD, the increased conversion of AA to its metabolites may reduce AA suppression of IA while increasing metabolite enhancement of IK, compromising the reliability of synaptic transmission (Colbert and Pan, 1999).

Recent evidence also suggests HAD related enhancement of glutaminase activity could result in an overabundance of glutamate (Erdmann et al. 2006). In experiments involving glutamate application, neuronal Kv2.1 channels were dephosphorylated (Misonou et al. 2004) and the activation curves shifted, resulting in greater open channel probability and current (Murakoshi et al. 1997). Further, Kv2.1 dephosphorylation leads to a dendritic beading which has been linked to potassium channel related LTP diminishment (Gelbard et al. 1994; Misonou et al. 2004; Bellizzi et al. 2005). Perhaps just as importantly, increasing Kv2.1 current has been shown to cause apoptotic loss of cell volume (Pal et al. 2003).

HAD models have further shown decreases in the concentration of BDNF (Nosheny et al. 2004). In addition to an essential role in neurogenesis, neuronal development, and neuronal survival, recent studies demonstrate BDNF down-regulates the expression of Kv1.2, Kv1.4, and Kv4.2 (Park et al. 2003) and may be essential for long-term potentiation and other forms of activity-dependent synaptic plasticity (Korte et al. 1996; Hartmann et al. 2001; Zakharenko et al. 2003). Interestingly, BDNF was found to reduce gp120 related neurotoxicity (Nosheny et al. 2005), possibly via down-regulation of A-type potassium channel genes and their associated currents.

Viral products

The viral protein Nef has also been detected in brain tissue (Ranki et al. 1995) and sera (Deacon et al. 1995) of AIDS patients. Furthermore, this soluble protein shares functional sequences with scorpion peptides known to interact with potassium channels (Garry et al. 1991; Werner et al. 1991) and has been demonstrated to reversibly increase total K+ current (Werner et al. 1991). These increased potassium currents may account for the neurotoxic effects Nef application causes in cultured human neurons (Trillo-Pazos et al. 2000).

Treatment with Kv Channel Antagonists

Kv channel blockade ameliorates macrophage-associated tissue damage

Reactive macrophage/microglial response leading to inflammatory tissue damage is now considered characteristic of a wide range of neurodegenerative disorders, including Alzheimer's disease, multiple sclerosis, and HIV associated dementia (Gendelman et al. 1998; Cotter et al. 1999; Rus et al. 2005). Consequently, many therapeutic approaches now attempt to modulate neuroinflammation in conjunction with symptomatic treatments (Judge and Bever, 2006; Judge et al. 2006). In light of the role of Kv channels in macrophage activation, secretion, migration, and proliferation, interest in developing effacious immunomodulatory Kv channel antagonists as an means of limiting neurodegeneration is growing (Judge and Bever, 2006; Judge et al. 2006). The use of both nonspecific Kv channel blockers (4-AP and 3,4-DAP) and highly selective blockers (margatoxin, kaliotoxin, and correolide) have been used to inhibit immune responses in rodent experimental allergic encepholomyelitis (EAE) models for multiple sclerosis (MS) (Beeton et al. 2001) and have now been clinically tested for treatment of patients with MS (Bever, 1994; Bever et al. 1994). In another in vivo study, injection of the Kv channel blocker quinidine in rats was found to ameliorate symptoms of clinical experimental allergic neuritis, an accepted animal model for human Guillain–Barre syndrome that is the peripheral nervous system counterpart of EAE in the CNS(Mix et al. 1989). Importantly, as expected the neuroprotective effects of these Kv channel inhibitors were accompanied by reduced inflammation in target tissue.

Kv channel blockade ameliorates HAD related neuronal dysfunction

Our lab has previously demonstrated i.c.v. injection of severe combined immunodeficient (SCID) mice with virus infected macrophage leads to impaired spatial learning and diminished long-term potentiation (Zink et al. 2002; Anderson et al. 2003), while also establishing that macrophage conditioned media increases neuronal IA and IK in culture(Hu D et al. 2007). We next studied the effects of systemic administration of the Kv channel antagonist 4-AP on LTP and animal behavior in our murine model of human HIV disease. We found the injection of HIV-1-infected human MDMs produced encephalitis, impaired spatial learning, and diminished long-term potentiation, which were ameliorated with administration of 4-AP (Keblesh et al. 2007).

At present it is difficult to estimate the relative contribution of neuronal and macrophage Kv channels. While 4-AP may protect neuronal physiology by blocking neuronal Kv channels, it may also mediate neuroprotective effects via inhibition of proinflammatory cytokine production from MDMs (Blunck et al. 2001; Qiu et al. 2002) and/or reduction of the migration, proliferation, and activation of additional macrophage. It is therefore our view that both macrophage and neuronal Kv channels be considered worthy targets for the development of new therapeutic strategies for chronic inflammatory and neurodegenerative disorders.


At present the complete mechanism of HIV-associated dementia has yet to be elucidated and as such, there is no effective prescribable treatment to date. At the same time, the role of voltage-gated potassium channels in the processes of macrophage activation, secretion, migration, and proliferation is just now beginning to be appreciated, while the effects of macrophage secreted cellular and viral factors on neuronal voltage-gated potassium channel current, and the significance of this for the neuron, are only gradually becoming clear. While this line of investigation into Kv channels and HAD pathogenesis is young it is also promising, and we hope to have provided a clear starting point and encouragement for future research in this area.


This work was supported by NIH grant R01 NS041862.


Copyright in this article, its metadata, and any supplementary data is held by its author or authors. It is published under the Creative Commons Attribution By licence. For further information go to:

Disclosure: The authors report no conflicts of interest.


  • Adle-Biassette H, Chretien F, Wingertsmann L, Hery C, Ereau T, Scaravilli F, Tardieu M, Gray F. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol. 1999;25:123–33. [PubMed]
  • Alkon DL. Ionic conductance determinants of synaptic memory nets and their implications for Alzheimer's disease. J Neurosci Res. 1999;58:24–32. [PubMed]
  • Alkon DL, Favit A, Nelson T. Evolution of adaptive neural networks: the role of voltage-dependent K+ channels. Otolaryngol Head Neck Surg. 1998;119:204–11. [PubMed]
  • Anderson ER, Boyle J, Zink WE, Persidsky Y, Gendelman HE, Xiong H. Hippocampal synaptic dysfunction in a murine model of human immunodeficiency virus type 1 encephalitis. Neuroscience. 2003;118:359–69. [PubMed]
  • Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789–99. [PubMed]
  • Bajetto A, Bonavia R, Barbero S, Florio T, Costa A, Schettini G. Expression of chemokine receptors in the rat brain. Ann N Y Acad Sci. 1999;876:201–9. [PubMed]
  • Balschun D, Wetzel W, Del Rey A, Pitossi F, Schneider H, Zuschratter W, Besedovsky HO. Interleukin-6: a cytokine to forget. Faseb J. 2004;18:1788–90. [PubMed]
  • Barak O, Goshen I, Ben-Hur T, Weidenfeld J, Taylor AN, Yirmiya R. Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120. Brain Res. 2002;933:98–108. [PubMed]
  • Beeton C, Barbaria J, Giraud P, Devaux J, Benoliel AM, Gola M, Sabatier JM, Bernard D, Crest M, Beraud E. Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation. J Immunol. 2001;166:936–44. [PubMed]
  • Bellinger FP, Madamba S, Siggins GR. Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. 1993;628:227–34. [PubMed]
  • Bellizzi MJ, Lu SM, Masliah E, Gelbard HA. Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor. J Clin Invest. 2005;115:3185–92. [PMC free article] [PubMed]
  • Bever CT., Jr The current status of studies of aminopyridines in patients with multiple sclerosis. Ann Neurol. 1994;36(Suppl):S118–121. [PubMed]
  • Bever CT, Jr, Young D, Anderson PA, Krumholz A, Conway K, Leslie J, Eddington N, Plaisance KI, Panitch HS, Dhib-Jalbut S, et al. The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial. Neurology. 1994;44:1054–9. [PubMed]
  • Birnbaum SG, Varga AW, Yuan LL, Anderson AE, Sweatt JD, Schrader LA. Structure and function of Kv4-family transient potassium channels. Physiol Rev. 2004;84:803–33. [PubMed]
  • Blunck R, Scheel O, Muller M, Brandenburg K, Seitzer U, Seydel U. New insights into endotoxin-induced activation of macrophages: involvement of a K+ channel in transmembrane signaling. J Immunol. 2001;166:1009–15. [PubMed]
  • Brabers NA, Nottet HS. Role of the proinflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. Eur J Clin Invest. 2006;36:447–58. [PubMed]
  • Budka H. Multinucleated giant cells in brain: a hallmark of the acquired immune deficiency syndrome (AIDS) Acta Neuropathol (Berl) 1986;69:253–8. [PubMed]
  • Bukrinsky M, Notte HSLM, Schmidtmayerova H, Dubrovsky L, Flanagan CR, Mullins ME, Lipton SA, Gendelman HE. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med. 1995;181:735–45. [PMC free article] [PubMed]
  • Burg ED, Remillard CV, Yuan JX. K+ channels in apoptosis. J Membr Biol. 2006;209:3–20. [PubMed]
  • Carlson KA, Limoges J, Pohlman GD, Poluektova LY, Langford D, Masliah E, Ikezu T, Gendelman HE. OTK18 expression in brain mononuclear phagocytes parallels the severity of HIV-1 encephalitis. J Neuroimmunol. 2004;150:186–98. [PubMed]
  • Coetzee WA, Amarillo Y, Chiu J, Chow A, Lau D, McCormack T, Moreno H, Nadal MS, Ozaita A, Pountney D, Saganich M, Vega-Saenz de Miera E, Rudy B. Molecular diversity of K+ channels. Ann N Y Acad Sci. 1999;868:233–85. [PubMed]
  • Colbert CM, Pan E. Arachidonic acid reciprocally alters the availability of transient and sustained dendritic K(+) channels in hippocampal CA1 pyramidal neurons. J Neurosci. 1999;19:8163–71. [PubMed]
  • Cotter R, Williams C, Ryan L, Erichsen D, Lopez A, Peng H, Zheng J. Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia. J Neurovirol. 2002;8:585–98. [PubMed]
  • Cotter RL, Burke WJ, Thomas VS, Potter JF, Zheng J, Gendelman HE. Insights into the neurodegenerative process of Alzheimer's disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity. J Leukoc Biol. 1999;65:416–27. [PubMed]
  • Cunningham AJ, Murray CA, O'Neill LA, Lynch MA, O'Connor JJ. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett. 1996;203:17–20. [PubMed]
  • David G, Modney B, Scappaticci KA, Barrett JN, Barrett EF. Electrical and morphological factors influencing the depolarizing after-potential in rat and lizard myelinated axons. J Physiol. 1995;489(Pt 1):141–57. [PubMed]
  • Deacon NJ, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker DJ, McPhee DA, Greenway AL, Ellett A, Chatfield C, Lawson VA, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan JS, Cunningham A, Dwyer D, Dowton D, Mills J. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science. 1995;270:988–91. [PubMed]
  • Debanne D, Guerineau NC, Gahwiler BH, Thompson SM. Action-potential propagation gated by an axonal I(A)-like K+ conductance in hippocampus. Nature. 1997;389:286–9. [PubMed]
  • Debanne D, Kopysova IL, Bras H, Ferrand N. Gating of action potential propagation by an axonal A-like potassium conductance in the hippocampus: a new type of non-synaptic plasticity. J Physiol Paris. 1999;93:285–96. [PubMed]
  • DeCoursey TE, Kim SY, Silver MR, Quandt FN. Ion channel expression in PMA-differentiated human THP-1 macrophages. J Membr Biol. 1996;152:141–57. [PubMed]
  • Dineley KT, Weeber EJ, Atkins C, Adams JP, Anderson AE, Sweatt JD. Leitmotifs in the biochemistry of LTP induction: amplification, integration and coordination. J Neurochem. 2001;77:961–71. [PubMed]
  • Dodson PD, Forsythe ID. Presynaptic K+ channels: electrifying regulators of synaptic terminal excitability. Trends Neurosci. 2004;27:210–7. [PubMed]
  • Dodson PD, Billups B, Rusznak Z, Szucs G, Barker MC, Forsythe ID. Presynaptic rat Kv1.2 channels suppress synaptic terminal hyperexcitability following action potential invasion. J Physiol. 2003;550:27–33. [PubMed]
  • Du J, Haak LL, Phillips-Tansey E, Russell JT, McBain CJ. Frequency-dependent regulation of rat hippocampal somato-dendritic excitability by the K+ channel subunit Kv2.1. J Physiol. 2000;522(Pt 1):19–31. [PubMed]
  • Elezgarai I, Diez J, Puente N, Azkue JJ, Benitez R, Bilbao A, Knopfel T, Donate-Oliver F, Grandes P. Subcellular localization of the voltage-dependent potassium channel Kv3.1b in postnatal and adult rat medial nucleus of the trapezoid body. Neuroscience. 2003;118:889–98. [PubMed]
  • Epstein LG, Gendelman HE. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol. 1993a;33:429–36. [PubMed]
  • Epstein LG, Gendelman HE. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechansims. Ann Neurol. 1993b;33:429–36. [PubMed]
  • Erdmann N, Whitney N, Zheng J. Potentiation of excitotoxicity in HIV-associated Dementia and the significance of glutaminase. Clinical Neuroscience Research. 2006;6:315–28. [PMC free article] [PubMed]
  • Fiala M, Looney DJ, Stins M, Way DD, Zhang L, Gan X, Chiappelli F, Schweitzer ES, Shapshak P, Weinand M, Graves MC, Witte M, Kim KS. TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol Med. 1997;3:553–64. [PMC free article] [PubMed]
  • Frick A, Magee J, Johnston D. LTP is accompanied by an enhanced local excitability of pyramidal neuron dendrites. Nat Neurosci. 2004;7:126–35. [PubMed]
  • Gabuzda DH, Ho DD, de la Monte SM, Hirsch MS, Rota TR, Sobel RA. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol. 1986;20:289–95. [PubMed]
  • Gallin EK. Ion channels in leukocytes. Physiol Rev. 1991;71:775–811. [PubMed]
  • Garry RF, Kort JJ, Koch-Nolte F, Koch G. Similarities of viral proteins to toxins that interact with monovalent cation channels. Aids. 1991;5:1381–4. [PubMed]
  • Gartner S. HIV infection and dementia. Science. 2000;287:602–4. [PubMed]
  • Gelbard HA, Nottet HS, Swindells S, Jett M, Dzenko KA, Genis P, White R, Wang L, Choi YB, Zhang D, et al. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol. 1994;68:4628–35. [PMC free article] [PubMed]
  • Gendelman H, Ding S, Nan G, Liu J, Ramirez S, Persidsky Y, Wang T, Volsky DJ, H X. Monocyte Chemotactic Protein-1 Regulates Voltage-Gated K+ Channels and Macrophage Transmigration. J NeuroImmune Pharmacol. 2008 Submitted. [PMC free article] [PubMed]
  • Gendelman HE. The Neuropathogenesis of HIV-1-Dementia. In: Gendelman HE, Lipton SA, Epstein LG, Swindells S, editors. The neurology of AIDS. 1. New York: Chapman and Hall; 1997a. pp. 1–10.
  • Gendelman HE, Zheng J, Coulter CL, Ghorpade A, Che M, Thylin M, Rubocki R, Persidsky Y, Hahn F, Reinhard J, Jr, Swindells S. Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J Infect Dis. 1998;178:1000–7. [PubMed]
  • Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Mizrachi Y, Volsky DJ, et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med. 1992;176:1703–18. [PMC free article] [PubMed]
  • Gerth A, Grosche J, Nieber K, Hauschildt S. Intracellular LPS inhibits the activity of potassium channels and fails to activate NFkappaB in human macrophages. J Cell Physiol. 2005;202:442–52. [PubMed]
  • Ghelardini C, Galeotti N, Bartolini A. Influence of potassium channel modulators on cognitive processes in mice. Br J Pharmacol. 1998;123:1079–84. [PMC free article] [PubMed]
  • Giese KP, Peters M, Vernon J. Modulation of excitability as a learning and memory mechanism: a molecular genetic perspective. Physiol Behav. 2001;73:803–10. [PubMed]
  • Giese KP, Storm JF, Reuter D, Fedorov NB, Shao LR, Leicher T, Pongs O, Silva AJ. Reduced K+ channel inactivation, spike broadening, and after-hyperpolarization in Kvbeta1.1-deficient mice with impaired learning. Learn Mem. 1998;5:257–73. [PubMed]
  • Glass JD, Wesselingh SL, Selnes OA, McArthur JC. Clinical neuropathologic correlation in HIV-associated dementia. Neurology. 1993;43:2230–7. [PubMed]
  • Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol. 1995;38:755–62. [PubMed]
  • Gonzalez-Scarano F, Martin-Garcia J. The neuropathogenesis of AIDS. Nat Rev Immunol. 2005;5:69–81. [PubMed]
  • Hartmann M, Heumann R, Lessmann V. Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. Embo J. 2001;20:5887–97. [PubMed]
  • Haslberger A, Romanin C, Koerber R. Membrane potential modulates release of tumor necrosis factor in lipopolysaccharide-stimulated mouse macrophages. Mol Biol Cell. 1992;3:451–60. [PMC free article] [PubMed]
  • Hille B. Ionic Channels in Excitable Membranes. 3rd. Sunderland, MA: Sinauer Associates; 2001.
  • Houzen H, Kikuchi S, Kanno M, Shinpo K, Tashiro K. Tumor necrosis factor enhancement of transient outward potassium currents in cultured rat cortical neurons. J Neurosci Res. 1997;50:990–9. [PubMed]
  • Hu D, Liu J, H X. Macrophage activates delayed-rectifier type K+ channels in cultured rat hippocampal neurons. The 37th Annual Meeting of the Society for Neuroscience; Nov 3 to 7; San Diego, California. 2007.
  • Jackson MB, Konnerth A, Augustine GJ. Action potential broadening and frequency-dependent facilitation of calcium signals in pituitary nerve terminals. Proc Natl Acad Sci U S A. 1991;88:380–4. [PubMed]
  • Johnston D, Christie BR, Frick A, Gray R, Hoffman DA, Schexnayder LK, Watanabe S, Yuan LL. Active dendrites, potassium channels and synaptic plasticity. Philos Trans R Soc Lond B Biol Sci. 2003;358:667–74. [PMC free article] [PubMed]
  • Judge SI, Bever CT., Jr Potassium channel blockers in multiple sclerosis: neuronal Kv channels and effects of symptomatic treatment. Pharmacol Ther. 2006;111:224–59. [PubMed]
  • Judge SI, Lee JM, Bever CT, Jr, Hoffman PM. Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment of central nervous system inflammation and degeneration. J Rehabil Res Dev. 2006;43:111–22. [PubMed]
  • Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature. 2001;410:988–94. [PubMed]
  • Keblesh J, Hu D, Dou H, Xiong H. 4-Aminopyridine-mediated neuroprotection in a murine model of HIV-1 encephalitis. 7th IBRO World Congress in Neuroscience; Melbourne, Australia. Jul. 12-15, 2007.2007.
  • Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 1986;233:1089–93. [PubMed]
  • Koller H, Siebler M, Hartung HP. Immunologically induced electrophysiological dysfunction: implications for inflammatory diseases of the CNS and PNS. Prog Neurobiol. 1997;52:1–26. [PubMed]
  • Korte M, Staiger V, Griesbeck O, Thoenen H, Bonhoeffer T. The involvement of brain-derived neurotrophic factor in hippocampal long-term potentiation revealed by gene targeting experiments. J Physiol Paris. 1996;90:157–64. [PubMed]
  • Kramer-Hammerle S, Rothenaigner I, Wolff H, Bell JE, Brack-Werner R. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res. 2005;111:194–213. [PubMed]
  • Kure K, Llena JF, Lyman WD, Soeiro R, Weidenheim KM, Hirano A, Dickson DW. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol. 1991;22:700–10. [PubMed]
  • Lewis RS, Cahalan MD. Potassium and calcium channels in lymphocytes. Annu Rev Immunol. 1995;13:623–53. [PubMed]
  • Lilliehook C, Bozdagi O, Yao J, Gomez-Ramirez M, Zaidi NF, Wasco W, Gandy S, Santucci AC, Haroutunian V, Huntley GW, Buxbaum JD. Altered Abeta formation and long-term potentiation in a calsenilin knock-out. J Neurosci. 2003;23:9097–106. [PubMed]
  • Lipton SA. HIV-related neurotoxicity. Brain Pathol. 1991;1:193–9. [PubMed]
  • Mackenzie AB, Chirakkal H, North RA. Kv1.3 potassium channels in human alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2003;285:L862–868. [PubMed]
  • Maruyama N, Kakuta Y, Yamauchi K, Ohkawara Y, Aizawa T, Ohrui T, Nara M, Oshiro T, Ohno I, Tamura G, et al. Quinine inhibits production of tumor necrosis factor-alpha from human alveolar macrophages. Am J Respir Cell Mol Biol. 1994;10:514–20. [PubMed]
  • McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N. Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol. 2003;9:205–21. [PubMed]
  • McLaughlin B, Pal S, Tran MP, Parsons AA, Barone FC, Erhardt JA, Aizenman E. p38 activation is required upstream of potassium current enhancement and caspase cleavage in thiol oxidant-induced neuronal apoptosis. J Neurosci. 2001;21:3303–11. [PubMed]
  • Meltzer MS, Skillman DR, Hoover DL, Hanson BD, Turpin JA, Kalter DC, Gendelman HE. Macrophages and the human immunodeficiency virus. Immunol Today. 1990;11:217–23. [PubMed]
  • Michaels J, Sharer LR, Epstein LG. Human immunodeficiency virus type 1 (HIV-1) infection of the nervous system: a review. Immunodefic Rev. 1988a;1:71–104. [PubMed]
  • Michaels J, Price RW, Rosenblum MK. Microglia in the giant cell encephalitis of acquired immune deficiency syndrome: proliferation, infection and fusion. Acta Neuropathol (Berl) 1988b;76:373–9. [PubMed]
  • Misonou H, Mohapatra DP, Park EW, Leung V, Zhen D, Misonou K, Anderson AE, Trimmer JS. Regulation of ion channel localization and phosphorylation by neuronal activity. Nat Neurosci. 2004;7:711–8. [PubMed]
  • Mix E, Olsson T, Solders G, Link H. Effect of ion channel blockers on immune response and course of experimental allergic neuritis. Brain. 1989;112(Pt 6):1405–18. [PubMed]
  • Murakoshi H, Trimmer JS. Identification of the Kv2.1 K+ channel as a major component of the delayed rectifier K+ current in rat hippocampal neurons. J Neurosci. 1999;19:1728–35. [PubMed]
  • Murakoshi H, Shi G, Scannevin RH, Trimmer JS. Phosphorylation of the Kv2.1 K+ channel alters voltage-dependent activation. Mol Pharmacol. 1997;52:821–8. [PubMed]
  • Murphy GG, Fedorov NB, Giese KP, Ohno M, Friedman E, Chen R, Silva AJ. Increased neuronal excitability, synaptic plasticity, and learning in aged Kvbeta1.1 knockout mice. Curr Biol. 2004;14:1907–15. [PubMed]
  • Nath A, Geiger J. Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog Neurobiol. 1998;54:19–33. [PubMed]
  • Nelson DJ, Jow B, Jow F. Lipopolysaccharide induction of outward potassium current expression in human monocyte-derived macrophages: lack of correlation with secretion. J Membr Biol. 1992;125:207–18. [PubMed]
  • Nicolini A, Ajmone-Cat MA, Bernardo A, Levi G, Minghetti L. Human immunodeficiency virus type-1 Tat protein induces nuclear factor (NF)-kappaB activation and oxidative stress in microglial cultures by independent mechanisms. J Neurochem. 2001;79:713–6. [PubMed]
  • Nosheny RL, Mocchetti I, Bachis A. Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration. Neurotox Res. 2005;8:187–98. [PubMed]
  • Nosheny RL, Bachis A, Acquas E, Mocchetti I. Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death. Eur J Neurosci. 2004;20:2857–64. [PubMed]
  • Nottet HS. The blood brain barrier: monocyte and viral entry into the brain. In: Gendelman HE, Grant I, P EI, Lipton SA, Swindells S, editors. The Neurology of AIDS. 2nd. Oxford, UK: Oxford Univesity Press; 2005. pp. 155–161.
  • Nottet HS, Gendelman HE. Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex. Immunol Today. 1995;16:441–8. [PubMed]
  • Olds JL, Anderson ML, McPhie DL, Staten LD, Alkon DL. Imaging of memory-specific changes in the distribution of protein kinase C in the hippocampus. Science. 1989;245:866–9. [PubMed]
  • Pal S, Hartnett KA, Nerbonne JM, Levitan ES, Aizenman E. Mediation of neuronal apoptosis by Kv2.1-encoded potassium channels. J Neurosci. 2003;23:4798–802. [PMC free article] [PubMed]
  • Park SY, Choi JY, Kim RU, Lee YS, Cho HJ, Kim DS. Downregulation of voltage-gated potassium channel alpha gene expression by axotomy and neurotrophins in rat dorsal root ganglia. Mol Cells. 2003;16:256–9. [PubMed]
  • Paulsen O, Sejnowski TJ. Natural patterns of activity and long-term synaptic plasticity. Curr Opin Neurobiol. 2000;10:172–9. [PMC free article] [PubMed]
  • Piomelli D, Volterra A, Dale N, Siegelbaum SA, Kandel ER, Schwartz JH, Belardetti F. Lipoxygenase metabolites of arachidonic acid as second messengers for presynaptic inhibition of Aplysia sensory cells. Nature. 1987;328:38–43. [PubMed]
  • Qiu MR, Campbell TJ, Breit SN. A potassium ion channel is involved in cytokine production by activated human macrophages. Clin Exp Immunol. 2002;130:67–74. [PubMed]
  • Ramakers GM, Storm JF. A postsynaptic transient K(+) current modulated by arachidonic acid regulates synaptic integration and threshold for LTP induction in hippocampal pyramidal cells. Proc Natl Acad Sci U S A. 2002;99:10144–9. [PubMed]
  • Ranki A, Nyberg M, Ovod V, Haltia M, Elovaara I, Raininko R, Haapasalo H, Krohn K. Abundant expression of HIV Nef and Rev. proteins in brain astrocytes in vivo is associated with dementia. Aids. 1995;9:1001–8. [PubMed]
  • Reike F, Warland R, de Ruyter van Steveninck R, Bialek W. Spikes: Exploring the Neural Code. Cambridge, MA: MIT Press; 1997.
  • Rus H, Pardo CA, Hu L, Darrah E, Cudrici C, Niculescu T, Niculescu F, Mullen KM, Allie R, Guo L, Wulff H, Beeton C, Judge SI, Kerr DA, Knaus HG, Chandy KG, Calabresi PA. The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proc Natl Acad Sci U S A. 2005;102:11094–9. [PubMed]
  • Schilling T, Quandt FN, Cherny VV, Zhou W, Heinemann U, Decoursey TE, Eder C. Upregulation of Kv1.3 K(+) channels in microglia deactivated by TGF-beta. Am J Physiol Cell Physiol. 2000;279:C1123–34. [PubMed]
  • Sekirnjak C, Martone ME, Weiser M, Deerinck T, Bueno E, Rudy B, Ellisman M. Subcellular localization of the K+ channel subunit Kv3.1b in selected rat CNS neurons. Brain Res. 1997;766:173–87. [PubMed]
  • Solntseva EI, Bukanova IuV, Skrebitskii VG. Memory and potassium channels. Usp Fiziol Nauk. 2003;34:16–25. [PubMed]
  • Southan AP, Robertson B. Electrophysiological characterization of voltage-gated K(+) currents in cerebellar basket and purkinje cells: Kv1 and Kv3 channel subfamilies are present in basket cell nerve terminals. J Neurosci. 2000;20:114–22. [PubMed]
  • Stoler MH, Eskin TA, Benn S, Angerer RC, Angerer LM. Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis Jama. 1986;256:2360–4. [PubMed]
  • Szucs A, Stefano GB, Hughes TK, Rozsa KS. Modulation of voltage-activated ion currents on identified neurons of Helix pomatia L. by interleukin-1. Cell Mol Neurobiol. 1992;12:429–38. [PubMed]
  • Tancredi V, D'Arcangelo G, Grassi F, Tarroni P, Palmieri G, Santoni A, Eusebi F. Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci Lett. 1992;146:176–8. [PubMed]
  • Thorn PJ, Wang XM, Lemos JR. A fast, transient K+ current in neurohypophysial nerve terminals of the rat. J Physiol. 1991;432:313–26. [PubMed]
  • Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice [see comments] Nature. 1994;367:188–93. [PubMed]
  • Trillo-Pazos G, McFarlane-Abdulla E, Campbell IC, Pilkington GJ, Everall IP. Recombinant nef HIV-IIIB. protein is toxic to human neurons in culture. Brain Res. 2000;864:315–26. [PubMed]
  • Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L, Griffin DE. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol. 1992;31:349–60. [PubMed]
  • Verani A, Gras G, Pancino G. Macrophages and HIV-1: dangerous liaisons. Mol Immunol. 2005;42:195–212. [PubMed]
  • Vicente R, Escalada A, Coma M, Fuster G, Sanchez-Tillo E, Lopez-Iglesias C, Soler C, Solsona C, Celada A, Felipe A. Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages. J Biol Chem. 2003;278:46307–20. [PubMed]
  • Visentin S, Renzi M, Levi G. Altered outward-rectifying K(+) current reveals microglial activation induced by HIV-1 Tat protein. Glia. 2001;33:181–90. [PubMed]
  • Wang X, Xiao AY, Ichinose T, Yu SP. Effects of tetraethylammonium analogs on apoptosis and membrane currents in cultured cortical neurons. J Pharmacol Exp Ther. 2000;295:524–30. [PubMed]
  • Watanabe S, Hoffman DA, Migliore M, Johnston D. Dendritic K+ channels contribute to spike-timing dependent long-term potentiation in hippocampal pyramidal neurons. Proc Natl Acad Sci U S A. 2002;99:8366–71. [PubMed]
  • Werner T, Ferroni S, Saermark T, Brack-Werner R, Banati RB, Mager R, Steinaa L, Kreutzberg GW, Erfle V. HIV-1 Nef protein exhibits structural and functional similarity to scorpion peptides interacting with K+ channels. Aids. 1991;5:1301–8. [PubMed]
  • Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A. 1986;83:7089–93. [PubMed]
  • Williams KC, Hickey WF. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci. 2002;25:537–62. [PubMed]
  • Xiao AY, Wei L, Xia S, Rothman S, Yu SP. Ionic mechanism of ouabain-induced concurrent apoptosis and necrosis in individual cultured cortical neurons. J Neurosci. 2002;22:1350–62. [PubMed]
  • Xiong H, Zeng YC, Lewis T, Zheng J, Persidsky Y, Gendelman HE. HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia. J Neurovirol. 2000;6(Suppl 1):S14–23. [PubMed]
  • Yeh MW, Kaul M, Zheng J, Nottet HS, Thylin M, Gendelman HE, Lipton SA. Cytokine-stimulated, but not HIV-infected, human monocyte-derived macrophages produce neurotoxic levels of l -cysteine. J Immunol. 2000;164:4265–70. [PubMed]
  • Yu SP. Regulation and critical role of potassium homeostasis in apoptosis. Prog Neurobiol. 2003;70:363–86. [PubMed]
  • Yu SP, Yeh CH, Sensi SL, Gwag BJ, Canzoniero LM, Farhangrazi ZS, Ying HS, Tian M, Dugan LL, Choi DW. Mediation of neuronal apoptosis by enhancement of outward potassium current. Science. 1997;278:114–7. [PubMed]
  • Zakharenko SS, Patterson SL, Dragatsis I, Zeitlin SO, Siegelbaum SA, Kandel ER, Morozov A. Presynaptic BDNF required for a presynaptic but not postsynaptic component of LTP at hippocampal CA1-CA3 synapses. Neuron. 2003;39:975–90. [PubMed]
  • Zeise ML, Madamba S, Siggins GR. Interleukin-1 beta increases synaptic inhibition in rat hippocampal pyramidal neurons in vitro. Regul Pept. 1992;39:1–7. [PubMed]
  • Zhao ML, Kim MO, Morgello S, Lee SC. Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis. J Neuroimmunol. 2001;115:182–91. [PubMed]
  • Zhou L, Messing A, Chiu SY. Determinants of excitability at transition zones in Kv1.1-deficient myelinated nerves. J Neurosci. 1999;19:5768–81. [PubMed]
  • Zink WE, Anderson E, Boyle J, Hock L, Rodriguez-Sierra J, Xiong H, Gendelman HE, Persidsky Y. Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis. J Neurosci. 2002;22:2096–105. [PubMed]
  • Zona C, Palma E, Pellerin L, Avoli M. Arachidonic acid augments potassium currents in rat neocortical neurones. Neuroreport. 1993;4:359–62. [PubMed]